Page last updated: 2024-10-29

ketamine and Lipid Metabolism, Inborn Error

ketamine has been researched along with Lipid Metabolism, Inborn Error in 2 studies

Ketamine: A cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE) and may interact with sigma receptors.
ketamine : A member of the class of cyclohexanones in which one of the hydrogens at position 2 is substituted by a 2-chlorophenyl group, while the other is substituted by a methylamino group.

Research Excerpts

ExcerptRelevanceReference
"Report a case of central diabetes insipidus (DI) associated with ketamine infusion."7.80Transient central diabetes insipidus induced by ketamine infusion. ( Felner, EI; Hatab, SZ; Kamat, P; Singh, A, 2014)
"Report a case of central diabetes insipidus (DI) associated with ketamine infusion."3.80Transient central diabetes insipidus induced by ketamine infusion. ( Felner, EI; Hatab, SZ; Kamat, P; Singh, A, 2014)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Prabhu, SS1
Khan, SA1
Doudnikoff, AL1
Mueller, N1
Reebye, UN1
Hatab, SZ1
Singh, A1
Felner, EI1
Kamat, P1

Other Studies

2 other studies available for ketamine and Lipid Metabolism, Inborn Error

ArticleYear
Anesthetic management for a patient with medium-chain acyl-CoA dehydrogenase deficiency in an outpatient setting using ketamine and fentanyl.
    Journal of clinical anesthesia, 2019, Volume: 56

    Topics: Acyl-CoA Dehydrogenase; Adolescent; Ambulatory Surgical Procedures; Anesthesia, Dental; Anesthesia,

2019
Transient central diabetes insipidus induced by ketamine infusion.
    The Annals of pharmacotherapy, 2014, Volume: 48, Issue:12

    Topics: 3-Hydroxyacyl CoA Dehydrogenases; Anesthetics; Cardiomyopathies; Cardiomyopathy, Hypertrophic; Child

2014